Craig Bijou

Stock Analyst at B of A Securities

(3.78)
# 757
Out of 5,044 analysts
63
Total ratings
60%
Success rate
54.64%
Average return

Stocks Rated by Craig Bijou

RxSight
Jul 9, 2025
Maintains: Underperform
Price Target: $18$9
Current: $8.81
Upside: +2.16%
PROCEPT BioRobotics
Apr 25, 2025
Maintains: Buy
Price Target: $104$84
Current: $36.95
Upside: +127.33%
Teleflex
Mar 4, 2025
Downgrades: Underperform
Price Target: $235$140
Current: $130.58
Upside: +7.21%
Bausch + Lomb
Feb 20, 2025
Maintains: Underperform
Price Target: $18$17
Current: $15.20
Upside: +11.84%
Globus Medical
Jan 9, 2025
Upgrades: Neutral
Price Target: $80$97
Current: $62.75
Upside: +54.58%
Integra LifeSciences Holdings
Oct 7, 2024
Maintains: Underperform
Price Target: $26$18
Current: $15.56
Upside: +15.68%
Integer Holdings
Oct 1, 2024
Maintains: Buy
Price Target: $135$145
Current: $68.00
Upside: +113.24%
Merit Medical Systems
Sep 16, 2024
Maintains: Neutral
Price Target: $92$103
Current: $82.75
Upside: +24.47%
Haemonetics
Sep 11, 2024
Initiates: Neutral
Price Target: $85
Current: $50.36
Upside: +68.78%
GE HealthCare Technologies
May 1, 2024
Maintains: Neutral
Price Target: $94$86
Current: $79.40
Upside: +8.31%
Initiates: Buy
Price Target: $95
Current: $71.75
Upside: +32.40%
Maintains: Buy
Price Target: $43$36
Current: $15.79
Upside: +127.99%
Reiterates: Overweight
Price Target: $23$45
Current: $8.52
Upside: +428.17%
Maintains: Overweight
Price Target: $15$120
Current: $4.81
Upside: +2,394.80%
Maintains: Neutral
Price Target: $60$30
Current: $4.86
Upside: +517.28%
Reiterates: Overweight
Price Target: $17$13
Current: $16.59
Upside: -21.62%
Maintains: Neutral
Price Target: $48$42
Current: $16.02
Upside: +162.17%
Reiterates: Overweight
Price Target: $207$230
Current: $545.39
Upside: -57.83%
Maintains: Neutral
Price Target: $190$230
Current: $375.93
Upside: -38.82%